News & Events

You are here

19 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include clinical trial site management organisation (SMO)...

27/11/15

NOVOGEN ENGAGES CONTRACT RESEARCH ORGANISATION TO CONDUCT CANTRIXIL PHASE 1 CLINICAL TRIAL

02/03/15

Novotech leads the fast growing Asia Pacific clinical research sector with another Frost & Sullivan "CRO BEST PRACTICE AWARD"

Sydney, Australia, February 17, 2015

Novotech, the largest Australia-based clinical CRO with offices throughout the Asia region, has just been awarded the CRO Best Practice Award for the third time in recent years by Frost...

19/01/15

Australian clinical research company expands operation in Hong Kong

Australian clinical research company expands operation in Hong Kong

Sydney-based Novotech today (January 15) announced that it...

19/12/14

SureClinical eTMF Cloud Selected by Novotech to automate and accelerate clinical operations processes

SureClinical eTMF Cloud Selected by Novotech to automate and accelerate clinical operations processes

Internationally recognized clinical research firm Novotech announces selection of...

30/09/14

NOVOTECH CRO EXPANDS ASIA REGION SERVICES WITH NEW CHINA OFFICE IN SHANGHAI

NOVOTECH CRO EXPANDS ASIA REGION SERVICES WITH NEW CHINA OFFICE IN SHANGHAI

Shanghai, China, 30 September, 2014 | Novotech, Australia’s largest clinical CRO with offices throughout Asia, announced today...

27/06/14

Clinical Trials in Asia – 10 Years on

In 2004, I authored an article entitled “Clinical Trials in Asia: A Promising Picture” on the potential of Asia as a significant contributor to global clinical drug development. The article was published in the Ernst and Young Annual Global...

15/06/14

NOVOTECH CRO ANNOUNCES MOU WITH KOREA DRUG DEVELOPMENT FUND (KDDF) AT DIA 2014

NOVOTECH CRO ANNOUNCES MOU WITH KOREA DRUG DEVELOPMENT FUND (KDDF) AT DIA 2014

San Diego, CA, June 15, 2014 | Novotech, Australia’s largest clinical CRO with offices throughout Asia, has...

10/05/14

Considerations for Asia Pacific clinical trials

As in many other industries, the emerging markets of Asia represent new frontiers for pharmaceutical and biotechnology companies. In recent years the widespread adoption of GCP across the region has meant the industry now is looking to Asia not...

10/03/14

Asian Century and clinical trials: Issues for consideration by biotechnology companies

As with many other industries, there is a prevailing belief that the 21st Century will be the Asian Century when it comes to drug development and the pharmaceutical industry. Already, markets such as China are predicted to overtake the US to...

23/06/13

Australian CRO Novotech announces expanded Asia reach into Hong Kong and Philippines at DIA 2013

Sydney, Australia, 23 June, 2013 – Novotech, Australia’s largest clinical CRO has expanded its Asia reach into Hong Kong and the Philippines, building on its established network which already includes a presence in Singapore, South Korea, Taiwan...

Pages